Issue 19, 2023

Research progress in nucleus-targeted tumor therapy

Abstract

The nucleus is considered the most important organelle in the cell as it plays a central role in controlling cell reproduction, metabolism, and the cell cycle. The successful delivery of drugs into the nucleus can achieve excellent therapeutic effects, which reveals the potential of nucleus-targeted therapy in precision medicine. However, the transportation of therapeutics into the nucleus remains a significant challenge due to various biological barriers. Herein, we summarize the recent progress in the nucleus-targeted drug delivery system (NDDS). The structures of the nucleus and nuclear envelope are first described in order to understand the mechanisms by which drugs cross the nuclear envelope. Then, various drug delivery strategies based on the mechanisms and their applications are discussed. Finally, the challenges and solutions in the field of nucleus-targeted drug delivery are raised for developing a more efficient NDDS and promoting its clinical transformation.

Graphical abstract: Research progress in nucleus-targeted tumor therapy

Article information

Article type
Review Article
Submitted
04 Jul 2023
Accepted
10 Aug 2023
First published
10 Aug 2023

Biomater. Sci., 2023,11, 6436-6456

Research progress in nucleus-targeted tumor therapy

S. Chen, R. Cao, L. Xiang, Z. Li, H. Chen, J. Zhang and X. Feng, Biomater. Sci., 2023, 11, 6436 DOI: 10.1039/D3BM01116J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements